New BRCA2 Gene Variants Associated with Moderate Risk of Breast Cancer
Researchers found 70 partially disruptive BRCA2 variants carry a 20% to 25% lifetime breast cancer risk, which may affect screening and treatment choices.
5 Articles
5 Articles
New BRCA2 gene variants associated with moderate risk of breast cancer
Mayo Clinic researchers, in a study published in Nature Communications, have identified a group of BRCA2 gene variants associated with a moderate risk of breast cancer, a finding that could help healthcare teams better assess a person's cancer risk and personalize care.
Mayo Clinic research sheds more light on BRCA2 variants and breast cancer risk
Mayo Clinic researchers took a closer look at a group of BRCA2 gene variants that only partially affect the function of that gene, resulting in a different level of breast cancer risk.
Mayo Clinic Study Finds Some BRCA2 Gene Changes Carry Lower Breast Cancer Risk
Mayo Clinic researchers, in a study published in Nature Communications, have identified a group of BRCA2 gene variants associated with a moderate risk of breast cancer, a finding that could help healthcare teams better assess a person's cancer risk and personalize care.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium





